The shareholders’ meeting of biosyn appointed Pascal Voltzenlugel as Managing Director/CEO of biosyn Arzneimittel GmbH. The Managing Director represents the company exclusively.
Pascal Voltzenlugel is a pharmacist, a graduate of the University of Strasbourg and holds an MBA (Master of Business Administration) from Noema Business Scholl. He has outstanding knowledge in the pharmaceutical and dermo-cosmetic industry and has worked in the DACH region, the USA and international markets in Europe, Latin America, the Middle East and South East Asia. Pascal Voltzenlugel has a long experience in the areas of prescription drugs, over-the-counter drugs, orphan drugs, medical devices, food supplements, aesthetics and cosmetic brands.
Pascal Voltzenlugel is a member of the Board of Directors of VIPS (Association of Pharmaceutical Companies in Switzerland) and was a member of the Board of Directors of the BPI (Federal Association of the Pharmaceutical Industry) Baden-Württemberg. He is also an administrator of the Board of Directors of the Swiss-French Chamber of Commerce.
As a committed CEO, with his expertise and skills, he is ideally prepared to further develop biosyn’s strengths and successfully master future challenges.
We wish Pascal Voltzenlugel every success in his new role.
